Release Date: 11/05/16 14:21 Summary: Change of Director's Interest Notice - Doug Snedden-BRS.AX Price Sensitive: No Download Document 430.3KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%